| Pharmaceutical active ingredients: |
| Ketoprofen |
| Available forms, composition and doses of Orucote: |
| N / A |
| Orucote medical category: |
| Human:Nonsteroidal anti-inflammatory drugs (NSAIDs) |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| M01AE03 - KetoprofenM02AA10 - Ketoprofen |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Ortrip | Nortriptyline Hydrochloride | Pharmasant Laboratories; Central Poly Trading |
| Ortrizol | Metronidazole | Profesional Medica Farcoral |
| Or-Tyl | Dicyclomine Hydrochloride | Ortega |
| Ortyn | Benzilone | Unidentified Pharmaceutical Company |
| Ortyn Retard | Benzilone | Unidentified Pharmaceutical Company |
| Orudis | Ketoprofen; Ketoprofen Sodium | Sanofi-Aventis; DKSH; Hawgreen; Metro Drug Distribution; Wyeth |
| Orudis E | Ketoprofen | Sanofi-Aventis; DKSH |
| Orudis EC | Ketoprofen | sanofi-aventis; Metro Drug Distribution |
| Orudis I.M. | Ketoprofen Sodium | Sanofi-Aventis; Hawgreen; IDS Group; Metro Drug Distribution; Wyeth |
| Orudis I.V. | Ketoprofen | Sanofi-Aventis; Metro Drug Distribution |